1. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009; 152:3‐13. doi: 10.1007/978-1-4419-
0284-9_1.
2. Chen Y, Yu XC, Xu SF, et al. Impacts of tumor location, nature and bone destruction of extremity osteosarcoma on selection of limb salvage operative procedure. Orthop Surg. 2016; 8(2): 139‐149. doi: 10.1111/os.12237.
3. Hegyi M, Semsei AF, Jakab Z, et al. Good prognosis of localized osteosarcoma in young patients treated with limb‐salvage surgery and chemotherapy. Pediatr Blood Cancer. 2011; 57)3): 415‐422. doi: 10.1002/pbc.23172.
4. Gharedaghi M, Peivandi MT, Mazloomi M, Shoorin HR, Hasani M, Seyf P, Khazaee F. Evaluation of Clinical Results and
Complications of Structural Allograft Reconstruction after Bone Tumor Surgery. Arch Bone Jt Surg. 2016 Jun;4(3):236-
42. PMID: 27517069; PMCID: PMC4969370.
5. Eleutério SJ, Senerchia AA, Almeida MT, et al. Osteosarcoma in patients younger than 12 years old without metastases
have similar prognosis as adolescent and young adults. Pediatr Blood Cancer. 2015; 62(7): 1209‐1213. doi:
10.1002/pbc.25459.
6. Ercolano LB, Christensen T, McGough R, et al. Treatment solutions are unclear for perimegaprosthetic infections. Clin
Orthop Relat Res. 2013; 471(10):3204–3213. doi: 10.1007/s11999-013-2852-7.
7. Ahlmann ER, Menendez LR, Kermani C, et al. Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb. J Bone Joint Surg Br. 2006; 88(6):790–795. doi: 10.1302/0301-620X.88B6.17519.
8. Capanna R, Morris HG, Campanacci D, et al. Modular uncemented prosthetic reconstruction after resection of
tumours of the distal femur. J Bone Joint Surg Br. 1994; 76(2):178– 186. PMID: 8113272.
9. Gosheger G, Goetze C, Hardes J, et al. The influence of the alloy of megaprostheses on infection rate. J Arthroplasty. 2008; 23(6):916–920. doi: 10.1016/j.arth.2007.06.015.
10. Shahpari O, Mousavian A, Elahpour N, Malahias MA, Ebrahimzadeh MH, Moradi A. The Use of Antibiotic
Impregnated Cement Spacers in the Treatment of Infected Total Joint Replacement: Challenges and Achievements. Arch
Bone Jt Surg. 2020 Jan;8(1):11-20. doi: 10.22038/abjs.2019.42018.2141. PMID: 32090140; PMCID:
PMC7007713.
11. Padgett DE, Silverman A, Sachjowicz F, et al. Efficacy of intraoperative cultures obtained during revision total hip
arthroplasty. J Arthroplasty. 1995; 10(4):420-6.doi: 10.1016/s0883-5403(05)80140-8.
12. Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003; 2(2):114-22. doi:
10.1038/nrd1008.
13. Singh PK, Schaefer AL, Parsek MR, et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with
bacterial biofilms. Nature. 2000; 407(6805):762-4. doi: 10.1038/35037627.
14. Portillo ME, Corvec S, Borens O, et al. Propionibacterium acnes: an underestimated pathogen in implant-associated
infections. BioMed Res Int. 2013; 2013:804391. doi: 10.1155/2013/804391.
15. Lass R, Giurea A, Kubista B, et al. Bacterial adherence to different components of total hip prosthesis in patients with
prosthetic joint infection. Int Orthop. 2014; 38(8):1597–1602. doi: 10.1007/s00264-014-2358-2.
16. Carmen JC, Roeder BL, Nelson JL, et al. Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics. Am J Infect Control. 2005; 33(2):78–82. doi: 10.1016/j.ajic.2004.08.002.
17. Sevelda F, Schuh R, Hofstaetter JG, et al. Total femur replacement after tumor resection: limb salvage usually achieved but complications and failures are common. Clin Orthop Relat Res. 2015; 473(6):2079–2087. doi:
10.1007/s11999-015-4282-1.
18. Taha M, Abdelbary H, Ross FP, et al. New Innovations in the Treatment of PJI and Biofilms - Clinical and Preclinical Topics. Curr Rev Musculoskelet Med. 2018; 11(3):380-388. doi: 10.1007/s12178-018-9500-5.
20. Gorman SP, Adair CG, Mawhinney WM. Incidence and nature of peritoneal catheter biofilm determined by electron and confocal laser scanning microscopy. Epidemiol Infect. 1994; 112(3):551-9. doi: 10.1017/s0950268800051256.
21. Keane PF, Bonner MC, Johnston SR, et al. Characterization of biofilm and encrustation on ureteric stents in vivo. Br J Urol. 1994; 73(6):687-91. doi: 10.1111/j.1464-410x.1994.tb07557.x.
22. Tunney MM, Patrick S, Gorman SP, et al. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Br. 1998; 80(4):568-72. doi: 10.1302/0301-620x.80b4.8473.
23. Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N
Engl J Med. 2007; 357(7):654-63. doi: 10.1056/NEJMoa061588.
24. Ribeiro TC, Honda EK, Daniachi D, et al. The impact of sonication cultures when the diagnosis of prosthetic joint infection is inconclusive. PLoS One. 2021; 16(7):e0252322. doi: 10.1371/journal.pone.0252322.
25. Puchner SE, Döring K, Staats K, et al. Sonication culture improves microbiological diagnosis of modular megaprostheses. J Orthop Res. 2017; 35(7):1383-1387. doi: 10.1002/jor.23406.
26. Roux V, Drancourt M, Stein A, et al. Corynebacterium species isolated from bone and joint infections identified by 16S
rRNA gene sequence analysis. J. Clin. Microbiol. 2004; 42(5):2231–2233. doi: 10.1128/JCM.42.5.2231-2233.2004.
)